Table 6 Univariate Cox regression analysis for locoregional failure and distant failure for subjects without recurrence or death in the first two years
Locoregional failure | Distant failure | |||||||
|---|---|---|---|---|---|---|---|---|
Event | HR | 95% CI | PValue | Event | HR | 95% CI | PValue | |
Gender | ||||||||
Male (n = 76) | 5 | 1.00 | 9 | 1.00 | ||||
Female (n = 21) | 2 | 1.41 | 0.27-7.29 | 0.68 | 0 | -- | -- | -- |
WHO Classification | ||||||||
Type III (n = 59) | 2 | 1.00 | 6 | 1.00 | ||||
Type II (n = 35) | 5 | 4.39 | 0.85-22.62 | 0.08 | 3 | 0.83 | 0.21-3.33 | 0.79 |
Type I (n = 3) | 0 | -- | -- | -- | 0 | -- | -- | -- |
cT | ||||||||
T1-2 (n = 62) | 3 | 1.00 | 4 | 1.00 | ||||
T3-4 (n = 35) | 4 | 2.47 | 0.55-11.05 | 0.24 | 5 | 2.25 | 0.61-8.41 | 0.22 |
cN | ||||||||
N0-1 (n = 27) | 1 | 1.00 | 2 | 1.00 | ||||
N2-3 (n = 70) | 6 | 2.64 | 0.32-22.02 | 0.37 | 7 | 1.49 | 0.31-7.19 | 0.62 |
Stage | ||||||||
IIB/III (n = 72) | 4 | 1.00 | 7 | 1.00 | ||||
IVA/IVB (n = 25) | 3 | 2.31 | 0.52-10.35 | 0.27 | 2 | 0.79 | 0.16-3.82 | 0.77 |
Treatment | ||||||||
CCRT group (n = 68) | 2 | 1.00 | 5 | 1.00 | ||||
NACT group (n = 29) | 5 | 6.31 | 1.22-32.59 | 0.03 | 4 | 1.87 | 0.50-6.96 | 0.35 |